ARTICLE | Clinical News
BritLofex lofexidine: Phase III data
June 23, 2008 7:00 AM UTC
Top-line data from a double-blind, U.S. Phase III trial showed that lofexidine met the primary endpoint of a significant reduction in withdrawal symptoms at day 3 compared with placebo. US WorldMeds s...